People: Chr Hansen Holding A/S (CHRH.CO)
Mr. Jesper Brandgaard has been Independent Director at CHR. HANSEN HOLDING A/S since November 28, 2017. He is Executive Vice President of Biopharm and Legal Affairs at Novo Nordisk A/S. He also serves as Chairman of SimCorp A/S and Member of Novo Nordisk Hemophilia Foundation Council. He has experience from group management in a multinational pharmaceutical company, including responsibility for strategy development and implementation, legal affairs and patents, information technology and investor relations. He has board and executive experience with financial reporting and capital markets.
|Total Annual Compensation, EUR||60,000|
|Restricted Stock Award, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||--|
|Fiscal Year Total, EUR||60,000|